期刊文献+

冠心病患者PCI手术前后血清髓过氧化物酶水平变化及临床意义 被引量:5

The changes of serum myeloperoxidase in patients with coronary heart disease pre and post intervention treatment
下载PDF
导出
摘要 目的:探讨冠心病( CHD)患者经皮冠状动脉介入术( PCI)治疗前后血清髓过氧化物酶( MPO)水平变化及临床意义。方法成功行PCI治疗的CHD患者80例( CHD组),其中稳定型心绞痛( SAP亚组)50例,不稳定型心绞痛( UAP亚组)患者30例,又根据冠状动脉Gensini积分分为重度病变亚组32例和非重度病变亚组48例;另选取非CHD志愿者20例为健康对照组。观察PCI术前及术后1 h和24 h时血清MPO水平改变,综合分析MPO改变与临床各指标的关系。结果 SAP亚组和UAP亚组患者术前MPO和CRP水平均高于健康对照组( P <0蜒.05)。与术前比较,PCI术后1 h MPO水平上升( P <0.05),24 h回落。重度病变亚组患者术前MPO和CRP水平均高于非重度病变亚组( P <0.05)。经PCI治疗后,重度病变亚组PCI术后1 h水平仍明显高于非重度病变亚组( P <0.05)。ROC分析可见术后24 h和△1(术后1 h-术前)、△3(术后24 h-术后1 h)的MPO水平有助于预测MACE的发生(AUC分别为0.823、0.769和0.845, P <0.05)。△1(术后1 h-术前)与MACE存在正相关( r =0.372, P <0.05),与Gensini积分存在正相关( r =0.392, P <0.05),△3(术后24 h-术后1 h)与MACE存在负相关( r =-0.329, P <0.05),与Gensini积分存在负相关( r =-0.435, P <0.05)。 Logistic回归发现Gensini积分(OR=1.03,95%CI 0.92~1.32, P <0.05)和△3(OR=1.12,95%CI 0.94~1.45, P <0.05)为MACE发生的独立危险因素。结论 PCI术后CHD患者血清MPO出现一过性波动,这种改变与冠状动脉狭窄程度和临床预后相关。 Objective To investigate the changes of serum myeloperoxidase ( MPO) level and its clinical significance in patients with coronary heart disease ( CHD) pre and post percutaneous coronary intervention ( PCI) .Methods Eighty ca-ses of successful PCI patients were enrolled as CHD group, among them, 50 cases of stable angina pectoris were enrolled as SAP subgroup, 30 patients with unstable angina pectoris were enrolled as UAP subgroup, and according to coronary Gensini score, they were divided into severe lesions subgroup ( n =32) and non-severe leisions subgroups ( n =48);selected non-CHD volunteers 20 cases as healthy control group.The changes of serum MPO levels before and 1 h and 24h post PCI were observed,the relationship between these clinical indexes were analyzed .Resu lts The SAP subgroup and UAP subgroup ’ s MPO and CRP levels were higher than those in healthy control group ( P 〈0.05).Compared with pre PCI, 1 h post PCI, MPO level were increased ( P 〈0.05) , after 24h, it was felled.Severe lesions subgroups’ preoperative MPO and CRP levels were higher than those in non-severe lesion group ( P 〈0.05).After PCI treatment, the severe lesion group after PCI 1h ’s level were still significantly higher than the non-severe lesion group ( P 〈0.05).After 24 h and △1 (after 1 h to before PCI ) ,△3 ( postoperative 24 h to 1 h after operation) , ROC analysis revealed that the levels of MPO helped to predict MACE (AUC were 0.823, 0.769 and 08.45 respectively, P 〈0.05).△1 (1 h after PCI to before PCI) and MACE exist positive correlation ( r =0.372, P 〈0.05),△1 and the Gensini score exists positive correlation ( r =0.392, P 〈0.05).△3 (24 h after PCI to 1 h after PCI) and MACE exist negative correlation ( r =-0.329, P 〈0.05), there is a negative correla-tion with Gensini score ( r =-0.435, P 〈0.05).Logistic regression analysis indicated that the Gensini score (OR=1.03, 95%CI 0.92-1.32, P 〈0.05) and△3 (OR=1.12, 95%CI 0.94-1.45, P 〈0.05) were independent risk factors of MACE.Conclusion After PCI, serum MPO showed fluctuation in CHD patients.This change correlated with the severity of coronary artery stenosis and clinical prognosis.
出处 《疑难病杂志》 CAS 2015年第7期664-667,F0003,共5页 Chinese Journal of Difficult and Complicated Cases
关键词 冠心病 经皮冠状动脉介入术 血清髓过氧化物酶 Coronary heart disease Percutaneous coronary intervention Serum myeloperoxidase
  • 相关文献

参考文献15

  • 1沈红元,陈玉蓉,沈建林.冠心病患者内皮细胞膜微粒及Th细胞因子水平变化及意义[J].检验医学与临床,2015,12(3):360-362. 被引量:8
  • 2沈云峰,胡远贵,张洪波.冠心病微生物感染状况与血清3种炎症标志物的相关性研究[J].检验医学与临床,2015,12(2):169-171. 被引量:6
  • 3曹琳.急诊应用门冬氨酸钾镁和胺碘酮治疗冠心病性快速心律失常的效果评价[J].检验医学与临床,2015,12(4):525-526. 被引量:30
  • 4陈璐瑶,赵树山,成光杰,石瑞正,张国刚.髓过氧化物酶基因多态性与冠心病易感性的Meta分析(英文)[J].中南大学学报(医学版),2014,39(3):217-231. 被引量:1
  • 5Haraguchi Y, Toh R, Hasokawa M, et al. Serum myeloperoxidase/parao- xonase 1 ratio as potential indicator of dysfunctional high-density lipo- protein and risk stratification in coronary artery disease[ J ]. Atheroscle- rosis,2014,234(2) :288-294.
  • 6Kataoka Y, Shao M, Wolski K, et al. Myeloperoxidase levels predict ac- celerated progression of coronary atherosclerosis in diabetic patients: in- sights from intravaseular ultrasound [ J ]. Atheroselerosis,2014,232 (2) : 377-383.
  • 7Bohensky M, Tacey M, Brand C, et al. Statin initiation and treatment non-adherence following a first acute myocardial infarction in patients with inflammatory rheumatic disease versus the general population [ J]. Arthritis Res Ther,2014,16(5 ) :443.
  • 8Larsen AI, Tomey MI, Mehran R, et al. Comparison of outcomes in pa- tients with ST-segment elevation myocardial infarction discharged on versus not on statin therapy (from the Harmonizing Outcomes With Re- vascularization and Stents in Acute Myocardial Infarction Trial) [ J]. Am J Cardiol,2014,113 ( 8 ) : 1273-1279.
  • 9Yang M, Shao XH, Zhu J, et al. Risk factors and incidence of stroke and MACE in Chinese atrial fibrillation patients presenting to emergency departments: a National wide database analysis[J]. Int J Cardiol,2014, 173 ( 2 ) : 242 -247.
  • 10Lloyd MM, Grima MA, Rayner BS, et al. Comparative reactivity of the myeloperoxidase-derived oxidants hypoehlorous acid and hypothioeya- nous acid with human coronary" artery endothelial cells [ J ]. Free Radic Biol Med,2013,65 : 1352-1362.

二级参考文献101

共引文献45

同被引文献38

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部